-+ 0.00%
-+ 0.00%
-+ 0.00%
Tiziana Life Sciences Hosts Webcast on Phase 2a Foralumab Trial Results
Share
Listen to the news
Tiziana Life Sciences Hosts Webcast on Phase 2a Foralumab Trial Results
  • Tiziana Life Sciences will attend BIO-Europe in Cologne, Germany, Nov. 9-11, 2026, seeking potential strategic partnerships.
  • CEO Ivor Elrifi will present Nov. 10 at 13:45 local time.
  • A key opinion leader webcast is scheduled for Nov. 9, 2026, at noon ET / 17:00 GMT.
  • The webcast will discuss positive Phase 2a INFORM-MS topline results for intranasal foralumab in non-active secondary progressive multiple sclerosis.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tiziana Life Sciences Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611090700OMX_____CNEWS_EN_GNW9873126_en) on November 09, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending